# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA618417 | B | Measuring the affinity of leukotriene synthesis inhibitor for 5-lipoxygenase activating protein by using [125I]L-691831 as radioligand. | 33 | single protein format | Scientific Literature | |||
2. | ALA622395 | A | plasma level at 2 hr after administration of the compound | Rattus norvegicus | 7 | organism-based format | Scientific Literature | ||
3. | ALA626387 | A | Bioavailability in rat | Rattus norvegicus | 8 | organism-based format | Scientific Literature | ||
4. | ALA700005 | F | Inhibition of calcium ionophore (A23187) stimulated LTB4 formation in human neutrophils | 18 | assay format | Scientific Literature | |||
5. | ALA873225 | F | Human whole blood was stimulated with calcium ionophore (A23187) and LTB 4 measured by enzyme immunoassay | 19 | tissue-based format | Scientific Literature | |||
6. | ALA701322 | F | The drug dependent inhibition of LTB4 biosynthesis in human whole blood (HWB) activated with the ionophore A-23187 | Homo sapiens | 29 | organism-based format | Scientific Literature | ||
7. | ALA856201 | F | In vitro inhibition of LTB4 biosynthesis in Ca++ ionophore activated human polymorphonuclear (HPMN) leukocytes. | Homo sapiens | 29 | organism-based format | Scientific Literature | ||
8. | ALA779724 | F | In vivo inhibitory activity against LTB4 biosynthesis by rat pleurisy model (v3h pre treatment time periods) | Rattus norvegicus | 1 | organism-based format | Scientific Literature | ||
9. | ALA781191 | F | Compound was tested in vivo against rat anaphylaxis in the peritoneal cavity | Rattus norvegicus | 12 | organism-based format | Scientific Literature | ||
10. | ALA879341 | F | Compound was evaluated in vivo for its functional activity(in percent) in a hyperreactive rat model of dyspnea | Rattus norvegicus | 8 | organism-based format | Scientific Literature |